Synthesis and structure-activity relationships of 2- and/or 4-halogenated 13β- and 13α-estrone derivatives as enzyme inhibitors of estrogen biosynthesis

about

Synthesis and structure-activity relationships of 2- and/or 4-halogenated 13β- and 13α-estrone derivatives as enzyme inhibitors of estrogen biosynthesis

Item

http://www.wikidata.org/entity/Q58718708

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в грудні 2018

@uk

name

Synthesis and structure-activi ...... itors of estrogen biosynthesis

@en

Synthesis and structure-activi ...... itors of estrogen biosynthesis

@nl

type

Item

label

Synthesis and structure-activi ...... itors of estrogen biosynthesis

@en

Synthesis and structure-activi ...... itors of estrogen biosynthesis

@nl

prefLabel

Synthesis and structure-activi ...... itors of estrogen biosynthesis

@en

Synthesis and structure-activi ...... itors of estrogen biosynthesis

@nl

P1476

Synthesis and structure-activi ...... itors of estrogen biosynthesis

@en

P2093

Bianka Edina Herman

http://www.w3.org/2001/XMLSchema#string

Csaba Tömböly

http://www.w3.org/2001/XMLSchema#string

Ildikó Bacsa

http://www.w3.org/2001/XMLSchema#string

Kevin Stefán Herman

http://www.w3.org/2001/XMLSchema#string

Mihály Szécsi

http://www.w3.org/2001/XMLSchema#string

Mónika Varga

http://www.w3.org/2001/XMLSchema#string

Rebeka Jójárt

http://www.w3.org/2001/XMLSchema#string

Tea Lanišnik Rižner

http://www.w3.org/2001/XMLSchema#string

P2860

Structural basis for androgen specificity and oestrogen synthesis in human aromatase

The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders

The Important Roles of Steroid Sulfatase and Sulfotransferases in Gynecological Diseases

Binary and ternary crystal structure analyses of a novel inhibitor with 17beta-HSD type 1: a lead compound for breast cancer therapy

The structure of a complex of human 17beta-hydroxysteroid dehydrogenase with estradiol and NADP+ identifies two principal targets for the design of inhibitors

Relationships between inhibition constants, inhibitor concentrations for 50% inhibition and types of inhibition: new ways of analysing data

17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor development.

Human placental estradiol-17 beta dehydrogenase. II. Kinetics and substrate specificities.

The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site.

Estrogen O-sulfamates and their analogues: Clinical steroid sulfatase inhibitors with broad potential.

P304

1271-1282

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14756366.2018.1490731

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

János Wölfling

Erzsébet Mernyák

Gyula Schneider

P577

2018-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30230387

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

drug discovery

P932

6147116

http://www.w3.org/2001/XMLSchema#string